CURASEPT ADS (anti discolouration system - see note 1) is a chlorhexidine (CHX) mouthwash without any of the known side effects of traditional CHX mouthwashes.
Your sense of taste is unaffected
Your teeth and tongue will not be discoloured
No painful irritation of the oral mucosa
Chlorhexidine (CHX) is used in dental medicine to inhibit the growth of bacteria. CHX even has a longterm effect: Bacterial plaque is kept at bay for eight to ten hours.
Indications
CHX is used whenever a mechanical check on plaque like teeth-cleaning is difficult or impossible: when gum problems arise or after operations, with implants or braces.
Side-effects
In the long term, traditional CHX applications lead to painful irritation of the oral mucosa, to changes in the sense of taste and to heavy brown discolouration of the tongue and the teeth.
Therefore
The use of CHX application CURASEPT ADS reduces all these side-effects to an almost imperceptible level. Thanks to CURASEPT ADS, there is usually no need for any time-consuming follow-up treatment to remove tooth discolouration.
A little note about SLS (sodium lauryl sulphate)
Although SLS is controversial, it is used in a large number of toothpastes as a foaming agent. SLS neutralises the long-term effect of CHX and reduces the effect of your CHX therapy enormously. During your CHX therapy, it is essential to use an SLS-free toothpaste.
The right toothpaste will support your CHX therapy. CURASEPT ADS gel toothpaste also contains CHX - and thus boosts the effect of your CHX mouthwash.
All CURASEPT ADS gel toothpastes are SLS-free to support the long-term effect of CHX.
Note 1 - Chlorhexidine with an anti discolouration system after periodontal flap surgery: a cross-over, randomized triple-blind clinical trial.
Cortellini P, Labriola A, Zambelli R, Pini Prato G, Nieri M, Tonetti MS,
J Clin Periodontol 2008; 35: 614-620. doi: 10.1111/j.1600-051X.2008.01238.x.
Abstract:
The use of chlorhexidine (CHX) has been recommended for a number of clinical applications including plaque control in the post operative period. However, the use of CHX is burdened with some side effects that could affect the compliance of the patient. The aim of this clinical trial was to evaluate the side effects, the staining in particular, the patient acceptance, and the efficacy of a 0.2% CHX mouthwash containing an anti discolouration system (ADS) compared with a 0.2% CHX alone, after periodontal flap surgery.
Conclusions:
ADS caused less pigmentation, was burdened by less side effects and was more agreeable than the control CHX; (2) CHX ADS was as effective as CHX without ADS in reducing gingival signs of inflammation in the post-surgical early healing phase; (3) the use of CHX ADS could be of value in treatment protocols in which the patient compliance with a CHX mouthwash prescription is relevant.
Clinical Relevance:
Scientific rationale for the study. The use of CHX mouth rinsing after periodontal flap surgery is a well established protocol to supplement modified and less effective mechanical oral hygiene measures. CHX, however, can cause some side effects that could affect patient compliance. A CHX ADS has been proposed that could be burdened by less side effects.
Principal findings: Use of a CHX ADS compared with CHX without ADS resulted in a similar efficacy in terms of reduction in post surgical gingival inflammation, and caused less side effects in terms of staining, alteration in food taste and salt perception and overall was preferred by patients to conventional CHX
Practical implications:
The use of CHX ADS could help patients to comply with professional prescriptions in treatment protocols in which the use of CHX mouthwash is relevant.
|
 |
| Your Basket |
|
Your basket contains no items totalling £0.00
|
|
